This protocol is judged by an institutional evaluate board, an impartial group that opinions any medical trials involving human beings. If a review involves a Agenda I drug, when the board approves the protocol as ethical, the scientists should submit an application for an investigational new drug (IND) range with the FDA.Weiser urged social websit